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Abstract
Background: Nanomaterials such as SiO2 nanoparticles (SiO2NP) are finding increasing applications in the
biomedical and biotechnological fields such as disease diagnostics, imaging, drug delivery, food, cosmetics and
biosensors development. Thus, a mechanistic and systematic evaluation of the potential biological and toxic effects
of SiO2NP becomes crucial in order to assess their complete safe applicability limits.
Results: In this study, human monocytic leukemia cell line THP-1 and human alveolar epithelial cell line A549 were
exposed to a range of amorphous SiO2NP of various sizes and concentrations (0.01, 0.1 and 0.5 mg/ml). Key
biological indicators of cellular functions including cell population density, cellular morphology, membrane
permeability, lysosomal mass/pH and activation of transcription factor-2 (ATF-2) were evaluated utilizing
quantitative high content screening (HCS) approach and biochemical techniques. Despite the use of extremely
high nanoparticle concentrations, our findings showed a low degree of cytotoxicity within the panel of SiO2NP
investigated. However, at these concentrations, we observed the onset of stress-related cellular response induced
by SiO2NP. Interestingly, cells exposed to alumina-coated SiO2NP showed low level, and in some cases complete
absence, of stress response and this was consistent up to the highest dose of 0.5 mg/ml.
Conclusions: The present study demonstrates and highlights the importance of subtle biological changes
downstream of primary membrane and endocytosis-associated phenomena resulting from high dose SiO2NP
exposure. Increased activation of transcription factors, such as ATF-2, was quantitatively assessed as a function of i)
human cell line specific stress-response, ii) SiO2NP size and iii) concentration. Despite the low level of cytotoxicity
detected for the amorphous SiO2NP investigated, these findings prompt an in-depth focus for future SiO2NP-cell/
tissue investigations based on the combined analysis of more subtle signalling pathways associated with
accumulation mechanisms, which is essential for establishing the bio-safety of existing and new nanomaterials.
Background
Nanoparticles have received increasing attention for
their potential applications in biology and medicine in
recent years [1-3]. Notably, atmospheric particulates,
such as diesel exhaust derivatives, have been recognized
to have harmful effects on human health, including sys-
temic and cardiovascular effects [4]. Lately, there has
been a growing awareness of the need to elucidate the
underlying interactions between cells and nanomaterials
in parallel with the development of nanomaterials appli-
cations, in order to ensure the safe implementation of
nanotechnologies. This has become increasingly empha-
sised by many research groups worldwide in a large
number of publications, in recent years [2,3,5-18]. As
silica nanoparticles (SiO2NP) are extensively used in the
biomedical field, for instance as biosensors for simulta-
neous assay of glucose [1], biomarkers for leukaemia cell
identification using optical microscopy imaging [17],
drug delivery [19], DNA delivery [20,21], cancer therapy
[22], and enzyme immobilization [23], it is important to
* Correspondence: bashmohamed@gmail.com
1Department of clinical medicine, Institute of Molecular Medicine, Trinity
College Dublin, Dublin8, Ireland
Full list of author information is available at the end of the article
Mohamed et al. Journal of Nanobiotechnology 2011, 9:29
http://www.jnanobiotechnology.com/content/9/1/29
© 2011 Mohamed et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.understand any potential and unintended toxic, func-
tional or signalling effects they may induce as a conse-
quence of their increased cellular access, compared to
their macroscale silica variants.
It has been reported that in vivo,i nam o u s em o d e l ,
ultrafine colloidal silica particles (diameter < 100 nm)
induce lung injury [24] and lung inflammation, which
manifest as neutrophil accumulation at early stage of
exposure (24 h) and chronic granulomatous inflamma-
tion at later stages (14 weeks) [25]. Furthermore, several
studies have also provided evidence that SiO2NP cause
abnormal clusters of topoisomerase I in the nucleoplasm
of cells, and pro-inflammatory stimulation both in vivo
and in vitro [26-29].
Lin et al. [30] demonstrated in an in vitro study that
amorphous SiO2NP (15 and 46 nm) significantly
reduced the viability of human alveolar epithelial cells
A549 in a dose- and time- dependent manner. They
also found that nanometre-sized SiO2NP inhibited DNA
replication, transcription, and cell proliferation. Low
toxicity induced by 200 nm-size (hereafter refer as nm
only) SiO2NP was reported by Wottrich et al. [31]. Con-
versely, a study by Brunner et al. found that SiO2NP
agglomerates (diameter > 200 nm) did not induce a
toxic effect either in vivo or in vitro [32]. Yu et al. also
reported that amorphous silica nanoparticles below 100
nm did not induce any cytotoxicity measured by the
mitochondrial viability assay [33].
In nanomaterial toxicity the study of the interaction of
the reporter assay dye compounds with nanoparticles
may cause significant interference with the assay perfor-
mance, for instance due to fluorescence shift [34].
Recently, a cell-based highc o n t e n ts c r e e n i n g( H C S )
assay operating on the principle of fully automated
fluorescence microscopy was introduced as a modern
drug discovery tool [35]. This technology is becoming
an indispensable approach to research and industry,
assisting in understanding complex cellular processes in
disease pathogenesis [36], drug target validation and
drug lead identification [37-39]. HCS assays are espe-
cially useful in studying cytotoxicity of nanomaterials,
because they allow for multiplexing of key reporter
parameters such as cell viability, permeability, mem-
brane potential, and lysosomal mass/pH [17,40,41].
Therefore special considerations have been given for the
experimental design of the cell-nanoparticles interaction
assessment to standardise every operation and remove
potential sources of inconsistency [5-7,40,42].
To elucidate whether the SiO2NP can induce stress-
related damage in living cells, the activation of transcrip-
tion factor-2 (ATF-2), following exposure to the
SiO2NPs, was investigated. ATF-2 is a member of the
basic region-leucine zipper transcription factor family
that regulates the expression of genes in response to
various stress signals, and it is known to acquire its
transcriptional activity upon phosphorylation by MAP
kinases, including JNK and p38 [43,44]. Because ATF-2
must be localised in the nucleus to induce gene expres-
sion, its translocation is a definitive measure of its acti-
vation, and marks an earlier event than reporter gene
expression [44,45].
The present experimental study was designed to carry
out a mechanistic and systematic multiparametric quan-
titative analysis of human cells responses to SiO2NP of
various sizes and concentrations utilising automated
HCS approach. Despite a low toxic response to SiO2NP
by all cell types in this study, as assessed by cell growth,
lysosomal mass/pH and cell membrane integrity, we
registered activation of gene stress marker ATF-2 thereby
indicating the triggering of stress-related signalling path-
ways prior to the onset of “classical” signs of cytotoxicity.
Methods
Reagents and Antibodies
Dulbecco’s modified Eagle medium (DMEM), RPMI
1640 and foetal bovine serum were from Gibco (Invitro-
gen, BioSciences Ltd., Dublin, Ireland). HitKit™ for
ATF-2 activation and multiparametric cytotoxicity assay
1 (MPCT1) were from Thermo Fisher Scientific
(Thermo Fisher Scientific Inc., USA). Rabbit monoclonal
anti-JNK, anti-phospho-JNK, anti-p38, anti-phospho-
p38 and horseradish peroxidase conjugated anti-rabbit
antibodies were from Cell Signaling Technology (Dan-
vers, MA, USA). PVDF membrane was obtained from
Pall Gelman Laboratories (Ann arbor, MI, USA). Acryla-
mide-bisacrylamide solution, Acrylogel (30%) was pur-
chased from BDH (VWR International Ltd., UK). ECL
plus reagent was purchased from Amersham (Arlington
Heights, IL, USA). All other reagents were from Sigma
(St Louis, MO, USA), unless indicated otherwise.
Cell culture
Two human cell lines, one phagocytic and one non-phago-
cytic origin were used: a monocytic leukaemia THP-1 and
an alveolar epithelial A549 (ATCC, Manassas, VA, USA).
A549 cells were cultured in DMEM and THP-1 cells in
RPMI 1640 medium. Both the culture media were supple-
mented with 10% foetal bovine serum, 200 mM L-gluta-
mine, 10000 U/ml penicillin and 10 mg/ml streptomycin.
For experimentation, A549 and THP-1 cells were seeded
in 96-well plates at 5000 and 15000 respectively (Nunc,
Inc., USA) and were maintained at 37°C and 5% CO2.
THP-1 cells were stimulated with 25 ng/ml of phorbol 12-
myristate 13-acetate for 72 h before SiO2NP exposure.
Nanoparticles
Three amorphous SiO2NP of different sizes (30, 80, and
400 nm) (Glantreo Ltd., Cork, Ireland) were evaluated
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40 nm, positively charged alumina coated chloride-ion
stabilized SiO2NP and 20 nm, sodium counterion stabi-
lised SiO2NP (Sigma-Aldrich, LUDOX CL 420883 and
LUDOX CL 420891 respectively). The physico-chemical
properties of all chosen nanoparticles such as size, sur-
face charge and pH have been fully characterised and
previously reported by Barnes et al. [46], (for reference
see Table 1, Barnes et al.) as part of a multisite evalua-
tion of nanoparticle complete characterization (Nanoin-
teract project under the European Union Framework
P r o g r a m m e6 ) .T h e s eS i O 2NP were used to study the
cellular toxic and stress responses in 6 and 96 well
plates of adherent cells exposed the above listed SiO2NP
at various concentrations (0.01, 0.1, and 0.5 mg/ml) for
1, 3, 6, and 24 h incubation. All assays were performed
in triplicate. After exposure, the cells were washed three
times with culture medium to remove any unbound and
non-internalised nanoparticles. Qualitative imaging of
the SiO2NP cell uptake was enabled by the use of fluor-
escently labelled SiO2NP (produced also by Glantreo
Ltd.). These were synthesised via a co-condensation
reaction where Rhodamine 6G soluble dye was incorpo-
rated into the silica framework during the synthesis of
the nanoparticles. It is known that by the incorporation
of the dye within the silica framework, the dye release is
prevented by the lack of charge transfer which is usually
associated with a surface functionalisation of the fluores-
cent dye [47]. Therefore, in our study when dispersed in
biological, or water based solutions no obvious differ-
ence between the unlabelled and Rhodamine 6G labelled
amorphous SiO2NP was found due to the complete
amorphous nature of the mesoporous silica.
High content screening and confocal microscopy
As mentioned, for the imaging of NP intracellular locali-
sation two custom modified fluorescently labelled
SiO2NP (30 nm and 400 nm) were used. To determine if
SiO2NP are endocytosed by active or passive transport
routes, cells were incubated at 37°C and 4°C, to monitor
a c t i v ea n dp a s s i v ed i f f u s i o n , respectively. THP-1 and
A549 cells were incubated with 0.01, 0.1 and 0.5 mg/ml
of these labelled SiO2NP for intervals ranging from 15
minutes to 24 h in a 37°C incubator with 5% CO2. Then,
cells were washed in phosphate-buffered saline solution
(PBS) at pH 7.4 and fixed in 3% paraformaldehyde (PFA).
For the 4°C assay, cells were exposed to the 0.1 mg/ml of
labelled SiO2NP (30 nm) for 24 h, and then cells were
fixed with 3% PFA. In order to observe the impact of pas-
sive transport on SiO2NP uptake, cells were pre-treated
with sodium azide for 3 h (0.1%, 0.015 M).
High resolution intracellular accumulation of fluores-
cently labelled nanoparticles was visualized by confocal
laser scanning microscopy (Carl Zeiss, Axiovert,
Germany). Two channel qualitative imaging was carried
out by acquiring a series of Z-stack images to verify the
accumulation of the particles within the cells as a func-
tion of particle concentration and exposure time. Cellu-
lar uptake of labelled SiO2NP (time-course and dose-
range) was further imaged and quantified using an auto-
mated IN Cell Analyzer 1000 HCA platform; (GE
Healthcare, UK) and IN Cell Investigator software (GE
Healthcare, UK), respectively.
Multiparameter cytotoxicity assay using HCS
A multiparametric cytotoxicity assay was performed
using Cellomics
® HCS reagent HitKit™ as per manufac-
turer’s instructions (Thermo Fisher Scientific Inc., USA).
This kit measures cell viability, cell membrane perme-
ability and lysosomal pH which are toxicity-attributed
phenomena. Variations in cell membrane permeability,
measured as changes in luminescence intensity, indi-
cated an enhancement of cell membrane damage and
decreased cell viability. It is known some toxins can
interfere with the cell’s functionality by affecting the pH
of organelles such as lysosomes and endosomes, or by
causing an increase in the number of lysosomes. The
dye used in the chosen cytotoxicity assay is a weak base
that accumulates in acidic organelles, such as lysosomes
and endosomes, which allows changes in lysosomal phy-
siology to be determined. For instance, an increase or
decrease in ph of acidic organelles and the changes in
lysosome numbers by compound toxicity results in a
decrease or an increased of fluorescence intensity,
respectively.
In agreement with a previous study, we took a toxicity
reference set by treating the cells with cisplatin (10 nM,
Sigma-Aldrich), which is a platinum-based chemother-
apy drug used to treat various types of cancers, includ-
ing sarcomas, some carcinomas (e.g. small cell lung
cancer, and ovarian cancer), lymphomas, and germ cell
tumours [48]. The experimental layout for the auto-
mated microscopic analysis, based on the In Cell analy-
zer 1000, was composed of untreated, cisplatin treated,
and SiO2NP treated plates. All these were scanned and
acquired in a stereology configuration of 6 randomly
selected fields. Images were acquired at 10 X magnifica-
tion using three detection channels with different excita-
tion filters. These included a DAPI filter (channel 1),
which detected blue fluorescence indicating nuclear
intensity at a wavelength of 461 nm; FITC filter (chan-
nel 2), which detected green fluorescence indicating cell
permeability at a wavelength of 509 nm and a TRITC
filter (channel 3), which detected lysosomal mass and
pH changes with red fluorescence at a wavelength of
599 nm.
The rate of cell viability and proliferation were
assessed by the automated analysis of the nuclear count
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cent staining intensities reflecting cell permeability
(FITC filter) and lysosomal mass/pH changes (TRITC
filter) were also quantified for each individual cell pre-
sent in the examined microscopic fields by IN Cell
Investigator (GE Healthcare, UK).
ATF-2 Activation Assay using HCS
ATF-2 activation was measured using Cellomics HitKit
®
as per manufacturer’s instructions (Thermo Fisher
Scientific Inc., USA). Briefly, cells seeded in 96-wells
plates as described above were incubated with the above
mentioned SiO2NP, for different intervals as previously
indicated in the text, and in addition anisomycin was
used as positive control (as supplied within the HitKit).
For MAPK inhibition assay cells were pre-treated for 30
min with specific inhibitors for p38 (pyridinyl imidazole
SB202190) or JNK (anthrapyraxolone SP600125) (Cal-
biochem, La Jolla, CA, USA). Exposed cells were then,
washed in PBS, fixed with 3% PFA and stained for ATF-
2 and nuclei (Hoechst). Plates were scanned, as pre-
viously described by using the principle of stereology in
a randomly selected number of fields, using automated
microscope (IN Cell Analyzer 1000 HCS platform, GE
Healthcare, Buckinghamshire, UK) and images were
acquired at 10 X magnification. Nuclear translocation of
ATF-2 was quantified by IN Cell Investigator software
using ad hoc nuclear trafficking analysis module (GE
Healthcare, UK).
Cell Lysis and Immunoblotting
Exposed cells were washed with ice-cold PBS and lysed
a t4 ° Cf o r3 0m i ni n5 0m MH E P E Sb u f f e r( p H7 . 4 )
containing NaCl 150 mM, MgCl2 1.5 mM, EGTA 1
mM, sodium pyrophosphate 10 mM, sodium fluoride 50
mM, b-glycerophosphate 50 mM, Na3VO4 1m M ,1 %
Triton X-100, phenylmethylsulphonyl fluoride 2 mM,
leupeptin 10 μg/ml and aprotinin 10 μg/ml. The result-
ing lysates were centrifuged at 16,000 × g for 15 min at
4°C and the protein content of the supernatants was
determined by the Bradford assay. Cell lysates were
boiled in Laemmli buffer (final concentration: Tris-HCl
62.5 mM, pH 6.7, Glycerol 10% v/v, sodium dodecyl sul-
phate 2% w/v, bromophenol blue 0.002% w/v and 143
mM b-mercaptoethanol) for 5 min. Equal amounts of
lysates were resolved by sodium dodecyl sulphate polya-
crylamide gel electrophoresis (SDS-PAGE). The sepa-
rated proteins were electrophoretically transferred to
polyvinylidene fluoride (PVDF) membrane by semi-dry
blotting for 1 h. The PVDF membranes were blocked in
5% non-fat dry milk in PBS Tween20 (PBST) [0.1% (v/v)
Tween20 in phosphate buffered saline (PBS)] for 1 h at
room temperature. After washing, the blots were incu-
bated with the indicated primary antibodies (diluted
according to manufacturer’s instructions) overnight at 4°
C with gentle rocking. After three washes in PBST, the
membranes were incubated with the horseradish peroxi-
dase conjugated secondary antibodies for 1 h at room
temperature. The immunoreactive bands were visualized
using an enhanced chemiluminescence detection system
(Amersham, Arlington Heights, IL, US) and subsequent
exposure to Kodak light sensitive film (Cedex, France).
Statistical analysis
The response of the two cell lines to the chosen SiO2NP
sizes and concentrations was analyzed by 2-way
ANOVA with Bonferroni post-test analysis with Graph-
Pad Prism v4 (GraphPad Software, USA). A p-value of
<0.05 was considered to be statistically significant. For
the multiparametric analysis, due to the large amount of
information acquired a data mining and exploration
platform was used (KNIME (http://KNIME.org, 2.0.3) in
combination with a screening module HiTS (http://
code.google.com/p/hits, 0.3.0) in order to screen and
normalised all parameters under investigation, as pre-
viously reported [49,50]. All measured parameters were
normalised using their respective percent of the positive
controls. Z score was used for scoring the normalised
values. These scores were summarised using the mean
function as follows Z score = (x-mean)/StDev, as from
previous work [51]. Heatmaps graphical illustration in a
colorimetric gradient table format was adopted as most
suitable schematic representation to report on any sta-
tistical significance and variation from normalised con-
trols based on their Z score value. Heatmaps tables
illustrate the range of variation of each quantified para-
meter from the minimum (green) through the mean
(yellow) to the maximum (red) accordingly to the para-
meter under analysis.
Densitometric Analysis
Densitometric analyses of the western blots were per-
formed as described previously [52] using GeneTools
s o f t w a r e( S y n g e n e ,C a m b r i d g e ,U K ) .T h er e l a t i v ev a l u e s
of the samples were determined by normalising all data
to the respective untreated control samples of each
experiment.
Results
Cellular uptake of SiO2NP
Two cell lines, a human monocytic leukemia cell line
THP-1 and a human alveolar epithelial cell line A549
were chosen to represent a physiologically relevant
model of the in vivo first line of interaction between
nanoparticles and human tissues, as it would be
expected following exposure of the lungs (inhalation)
and uptake of foreign material by phagocytic system uti-
lizing innate immunity mechanisms. Confirmation of
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uptake by both THP-1 and A549 cell lines was observed
by confocal microscopy after 24 h (Figure 1A, 1B).
Transmission electron microscopy (TEM) imaging
clearly show the absence of significant aggregated clus-
ters of 40 nm size alumina coated particles (Figure 1C)
w h e r ep a r t i c l es i z em e a s u r e m e n t sh a v eb e e na l s o
included for clarity. Further to this, Light Scattering
measurement was also carried out on retrieved 40 nm
particles, and this did not show any significant aggrega-
tion as shown in (Additional file 1, Figure S1).
The evaluation of the rate of the cellular uptake of the
labelled SiO2NP, versus untreated controls, relative
fluorescent intensity was quantified after 24 h exposure
(Figure 2, 3). As expected for all SiO2NP, THP-1 cells
rapidly engulfed these nanoparticles, with a maximum
uptake for 30 nm labelled SiO2NP at 0.1 mg/ml and
higher concentrations (0.5 mg/ml). When comparing
the accumulation rate, THP-1 cells engulfed the SiO2NP
at a faster rate than the A549 cells which is totally
acceptable due to the specialist phagocytic nature of the
THP-1 cells. In addition for both cell lines, the intracel-
lular accumulation of the 400 nm-size SiO2NP was
slower when compared to the 30 nm particles. Next, we
investigated whether the cellular uptake of the SiO2NP
was mediated by an energy-dependent mechanism; thus
t h ec e l l sw e r ei n c u b a t e da tb o t h3 7 ° Ca n d4 ° Cu pt o2 4
h with fluorescently labelled 30 nm SiO2NPs (0.1 mg/
ml). THP-1 and A549 cells incubated at 4°C exhibited a
significant reduction in the SiO2NP uptake compared to
the equivalent incubation at 37°C (Figure 3A, 3B).
Moreover, by blocking the active transport mechanism
of the A549 cells by sodium azide treatment this signifi-
cantly impeded SiO2NP uptake, as shown in Figure 3B;
t h i sw a sn o tt h ec a s ef o rt h eT H P - 1c e l ll i n ew h e r et h e
sodium azide was not sufficiently adequate to block the
SiO2NP uptake (Figure 3A). However, increased concen-
trations of sodium azide significantly blocked the uptake
of SiO2NP (data not shown).
Cell viability and proliferation assessment in response to
SiO2NP
The assessment of cell-SiO2NP interaction by means of
viability and proliferation of THP-1 and A549 cells
respectively was performed by HCS on the all the cho-
sen SiO2NP (20, 30, 40, 80, 400 nm) as fully described
in the material section. In addition, for each particle
size the results are presented in colorimetric gradients
(heatmap format table), as shown in Figure 4 and 5 for
THP-1 and A549 respectively and also by statistical
analysis (Additional file 1, Table S1a-c). THP-1 did not
show any obvious viability reduction up to 6 h when
compared to the untreated cellular control (Figure 4,
“cell viability” column for each particle size analysed
( A ,B ,C ,D ,E ,i n c u b a t i o nt i m ei n c r e a s i n gf r o mt o pt o
bottom). There, a significant decrease in the cell viabi-
lity was seen for the sodium counterion stabilised (20
nm) SiO2NP at 0.1, or 0.5 mg/ml (Figure 4A), for the
30 nm SiO2NP at 0.5 mg/ml (Figure 4B), and for the
80 nm or 400 nm SiO2NP at 0.01, 0.1, or 0.5 mg/ml
(Figure 4D, 4E). Interestingly, no significant effect in
the THP-1 cell viability was recorded for any of the
tested doses of the alumina coated positively charged
SiO2NP (40 nm) (Figure 4C) up to 24 h, also con-
firmed by their statistical analysis tables (Additional
Figure 1 Confocal microscopic image of A549 cells showing
SiO2NP uptake. (A) A549 cells growing on Permanox
® chamber
slide were incubated with Rhodamine labelled SiO2NP (30 nm) for
24 h. After this time, culture media was carefully removed, cells
were washed in PBS and cells were fixed in 3% paraformaldehyde.
Nuclei were stained with Hoechst (blue). A representative sample
population of cells were visualized by confocal microscopy using a
63 X oil immersion lens. (B) Three dimensional image stacks
showing cytosolic accumulation of 30 nm SiO2NP (Z-stack = 27
slices at 0.45 μm per slices, Z-height 12.15 μm), (top image = x-z
plane; centre image = x-y plane; right image = y-z plane). (C)
Transmission Electron Microscope (TEM) image shows SiO2NP
cytoplasmic accumulation, particle size distribution within an A549
epithelial lung cell (magnification 10 x and 120 KeV accelerating
voltage).
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Page 5 of 14Figure 3 Cellular uptake under low temperature condition and in the presence of metabolic inhibitor. THP-1 (A) and A 549 (B) cells were
exposed to 0.01 mg/ml of 30 nm SiO2NP over 1- 24 h time pried at 37°C, 4°C and 0.1% sodium azide. High content screening analysis for the
cytosolic uptake of these particles was performed using an automated IN Cell Analyzer 1000 microscope and IN Cell Investigator image analysis
software. Relative fluorescence intensity (RFU) represents the average of intensity value of cytosolic accumulation of these labelled nanoparticles
when measured in PBS at pH 7.4. Data shown is normalised to untreated control and presented as mean values of three independent
experiments performed in triplicate samples. Statistical analysis was carried out by 2-way ANOVA with Bonferroni post-test analysis and
statistically significant data is reported by “*” symbol, for p < 0.05; “**” p < 0.01; “***” for p < 0.001.
Figure 2 Cellular uptake of 30 nm and 400 nm SiO2NP. THP-1 (A, B) and A549 (C, D) cells growing on 96-well plates were exposed to
various concentrations (0.01, 0.1, or 0.5 mg/ml) of 30 nm (A, C) or 400 nm (B, D) SiO2NP for multiple time points ranging from 15 min to 24 h.
High content screenings analysis for the cytosolic accumulation of these particles was performed using an automated IN Cell Analyzer 1000
microscope and IN Cell Investigator image analysis software. Relative fluorescence intensity (RFU) represents the average intensity value of
cytosolic accumulation of these labelled nanoparticles when measured in PBS at pH 7.4. Data shown is normalised to untreated control and
presented as mean values of three independent experiments performed in triplicate samples. 2-way ANOVA with Bonferroni post-test analysis
was carried out on the experimental data, normalised to controls, and statistically significant data is reported by “*” symbol, for p < 0.05; “**” p <
0.01; “***” for p < 0.001.
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Page 6 of 14file 1, Table S1a-c). Conversely to the THP-1 cell line,
no detectable effect on A549 cell viability was observed
by any of the SiO2NP type or doses investigated in this
study (Figure 5A-E).
Changes in cell membrane permeability in response to
SiO2NP
Further assessment of cell-SiO2NP interaction by means
of cellular membrane permeability tests on THP-1 and
A549 cells was performed by HCS on the all investigated
SiO2NP (20, 30, 40, 80, 400 nm). In fact, it is known that
the alterations of the cellular membrane permeability
indicate the alterations of the physical condition of the
cells [53]. For THP-1 cells the cellular membrane perme-
ability was significantly increased over 24 h exposures to
20, 30 or 80 nm-size SiO2NP at 0.5 mg/ml concentration
(Figure 4A, 4B, 4D). On the other hand, no significant
changes were seen for the 40 nm and 400 nm SiO2NP at
any concentrations (Figure 4C, 4E).
For the A549 cells at concentration of 0.5 mg/ml, no
significant changes in the cell membrane permeability
was seen upon exposure to 20, 30, 40 and 80 nm
SiO2NP at all tested doses and incubation times when
compared to the untreated control cells (Figure 5A-D)
and confirmed by ANOVA statistical test (Additional
file 1, Table S2a-c). In contrast, the 400 nm-size
SiO2NP caused cell membrane alteration at different
incubation times, as shown in Figure 5E
Changes in lysosomal mass/pH in response to SiO2NP
The assessment of cell lysosomal mass/pH in response to a
range of SiO2NP with different sizes (20, 30, 40, 80, 400
nm) was performed by HCS tool. A decrease or an increase
of lysosomal mass/pH can designate an increased rate of
the cytotoxicity. In this study, no significant changes were
detected in lysosomal mass/pH staining intensity up to 6 h
exposure to 20, 30, 80 nm SiO2NP at any of the concentra-
tions tested in THP-1 cells. Conversely, the lysosomal
mass/pH was markedly diminished in the THP-1 cells at
the highest concentration (0.5 mg/ml) of the (20, 30 or 80
Figure 5 Heatmaps tables illustrating toxicity indicated
parameters in A549 cells exposed to SiO2NP. A549 cells growing
on 96-well plates were exposed to various concentrations (0.01, 0.1,
or 0.5 mg/ml) of 20 nm (A), 30 nm (B), 40 nm (C), 80 nm (D), or 400
nm (E) SiO2NP for 1 h, 3 h, 6 h, or 24 h. Multi-parameter high
content screening analysis for cell count, Lysosomal mass/pH and
cell membrane permeability (MP) was performed using an
automated IN Cell Analyzer 1000 microscope and IN Cell
Investigator image analysis software. Data represents three
independent experiments performed in triplicate samples. Heatmaps
colorimetric gradient table for the A549 results span from: Dark
green = lower than 15% of maximum value measured; Bright green
= 30%; Yellow = 50%; Bright Orange = 60%; Dark Orange = 75%;
Red = higher than 75% of maximum value. Cell viability colour
gradients read as percentage of cell loss compared to normalised
control (green = low cell viability loss, red = high loss) compared to
normalised control. Heatmaps values are normalised using the
percent of the positive controls and, Z score was calculated as
described in the statistical analysis section.
Figure 4 Heatmaps tables illustrating toxicity indicated
parameters in THP-1 cells exposed to SiO2NP. THP-1 cells
growing on 96-well plates were exposed to various concentrations
(0.01, 0.1, or 0.5 mg/ml) of 20 nm (A), 30 nm (B), 40 nm (C), 80 nm
(D), or 400 nm (E) SiO2NP for 1 h, 3 h, 6 h, or 24 h. Multiparametric
high content screening analysis for cell count (left column),
Lysosomal mass/pH (middle column) and cell membrane
permeability (MP) (right column) was performed using an
automated IN Cell Analyzer 1000 microscope and IN Cell
Investigator image analysis software. Data represents three
independent experiments performed in triplicate samples. Heatmaps
were generated for the above indicated parameters and their
colorimetric gradient table spans from: Dark green = lower than
15% of maximum value measured; Bright green = 30%; Yellow =
50%; Bright Orange = 60%; Dark Orange = 75%; Red = higher than
75% of maximum value. Cell viability colour gradients read as
percentage of cell loss compared to normalised control (green =
low cell viability loss, red = high loss) compared to normalised
control. Heatmaps values are normalised using the percent of the
positive controls and, Z score was calculated as described in the
statistical analysis section.
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4D). However, 40 nm alumina coated SiO2NP and 400
nm-size uncoated SiO2NP did not induce any lysosomal
mass/pH staining intensity changes for all tested doses in
the THP-1 cell line, (Figure 4C, 4E). The lysosomal mass/
pH staining intensity was increased in A549 cells following
24 h exposure to 20 and 80 nm SiO2NP at 0.5 mg/ml (Fig-
ure 5A, and 5D) and to 400 nm-size SiO2NP at 0.1 and 0.5
mg/ml concentrations (Figure 5E). Conversely, 40 nm alu-
mina-coated SiO2NP did not induce any changes in the
lysosomal mass/ph at any investigated concentrations in
the A549 cells (Additional file 1, Table S3a-c).
SiO2NP induces ATF-2 nuclear translocation in cultured
cells
To assess whether cells exposed to any of the SiO2NP
under investigation showed gene stress response, we
measured ATF-2 activation by nuclear translocation.
A549 and THP-1 cells were exposed to SiO2NP for var-
ious time points (1, 3, 6, or 24 h) and ATF-2 nuclear
translocation was measured by HCS system. ATF-2 was
absent in the nuclei of untreated A549 cell (Figure 6)
and THP-1 cells (data not shown). Quantitative analysis
by HCS demonstrated that in both cell types ATF-2
underwent nuclear translocation upon nanoparticles
exposure. The nuclear translocation of ATF-2 was size-
dependent across the SiO2NP tested. For A549 cells, it
resulted in a clear incremental dose-translocation pro-
portion, starting from 3 h exposure; whereas for THP-1
c e l l st h i sp h e n o m e n o nw a so b v i o u sa f t e r6h .I nb o t h
cases it reached a plateau at 24 h exposure (Figure 7).
Despite the similar dynamics of ATF-2 activation regis-
tered for both the cell lines, the overall activation level
was lower in A549 cells than that observed in THP-1
cells (Figure 7B vs 7A). In addition, labelled SiO2NP
also induced ATF-2 activation in both THP-1 and A549
cells (Figure 8A, 8B). This was not observed following
the blocking of active transport mechanisms in THP-1
and A549 cell lines either by sodium azide treatment or
by low temperature conditions (4°C)
SiO2NP induced activation of ATF-2 is dependent on JNK
and p38
In addition to qualitative and quantitative assessment of
the ATF-2 activation in both cell lines, we also
Figure 7 Heatmaps tables illustrating SiO2NP induced nuclear
translocation of ATF-2. THP-1 (A), or A549 (B) cells growing on 96-
well plates were exposed to various concentrations (0.01, 0.1, or 0.5
mg/ml) of 20 nm, 30 nm, 40 nm, 80 nm, or 400 nm SiO2NP for 1 h,
3 h, 6 h, or 24 h. Cells were labelled with the Cellomics
® HCS
reagent kit for ATF-2 activation. High content screening analysis for
nuclear translocation of ATF-2 was performed using an automated
IN Cell Analyzer 1000 microscope equipped with IN Cell Investigator
image analysis software that quantifies nuclear to cytoplasmic
fluorescence intensity. Data represents three independent
experiments performed in triplicate samples. Heatmaps colorimetric
gradient table for the A549 results span from: Dark green = lower
than 15% of maximum value measured; Bright green = 30%; Yellow
= 50%; Bright Orange = 60%; Dark Orange = 75%; Red = higher
than 75% of maximum value. Heatmaps values are normalised using
the percent of the positive controls and, Z score was calculated as
described in the statistical analysis section.
Figure 6 Effect of SiO2NP on ATF-2 translocation in A549 cells.
A549 cells were exposed to 0.5 mg/ml SiO2NP (30 nm) or
anisomycin (positive control) for 24 h and fixed in 3%
paraformaldehyde. Cells were labelled with the Cellomics
® HCS
reagent kit for ATF-2 activation (green). Nuclei were stained with
Hoechst (blue). Cellular images were acquired by an IN Cell Analyzer
1000 automated microscope using 10 X objective (Image size: 0.897
mm × 0.671 mm). Red arrows indicate representative cells with
activated ATF-2.
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response to SiO2NP was dependent on earlier upstream
changes in relevant intracellular signalling mechanisms.
In the model of A549 cells we investigated if SiO2NP
exposure involved intracellular signalling cascade path-
ways such as JNK and/or p38. It is known that the acti-
vation of ATF-2 results from phosphorylation at Ser 69/
71 by either JNK or p38 kinase [44,45]. Thus, A459 cells
that had been exposed to SiO2NP (i.e., 80 nm) for vary-
ing time points ranging from 15 min to 24 h were ana-
lyzed for JNK or p38 activation by Western
immunoblotting. We found that SiO2NP (80 nm) signifi-
cantly increased the level of phosphorylated JNK1/2 as
well as p38 in all cases when compared to untreated
control cells (Figure 9A, 9B).
We next studied whether ATF-2 nuclear translocation
in response to SiO2NP was dependent on p38 and/or
JNK activation. For this purpose, specific inhibitors of
these MAPK were utilised. A pyridinyl imidazole
SB202190 and an anthrapyraxolone SP600125 are well-
characterised and specific inhibitors of p38 and JNK
respectively [54-56]. Pre-treatment of the cells with
SB202190 (10 μM) blocked SiO2NP-induced ATF-2
nuclear translocation (Figure 10). Similarly, pre-treat-
ment of the cells with anthrapyraxolone SP600125 (10
μM) significantly reduced SiO2NP-induced ATF-2
nuclear translocation (Figure 10). Together, these results
confirmed that SiO2NP induced ATF-2 activation was
dependent on p38 and JNK, further supporting their
roles in the activation of ATF-2.
Discussion
In this study, we explored the potential cytotoxic effect
of SiO2NP of five sizes (20, 30, 40, 80 and 400 nm), and
dose-ranges from 0.01 to 0.5 mg/ml, in two cultured
human cells of diverse origin: (i) a phagocytic cell line
THP-1, and (ii) a lung epithelial cell line A549. We have
demonstrated the cellular uptake of SiO2NP by confocal
microscopy and HCS in both the cell lines. Active or
passive transport routes of SiO2NP endocytosis were
examined by temperature controlled assays at 37°C or 4°
C, respectively. To further expand this work and gain a
deeper understanding on the subtle cell stress variation
at molecular level we investigated the activation of tran-
scription factor-2 (ATF-2). To date, this is the first
quantitative study showing treatment of human cell
lines with SiO2NP (unstabilised or sodium stabilized)
induces activation of ATF-2 in a dose- and time-depen-
dent manner. This activation was found to be dependent
on JNK and p38 kinase-mediated signalling pathways
and we have shown that JNK and p38 are phosphory-
lated by SiO2NP treatment of cells. The involvement of
p38 cell stress activated pathway is also supported by
the evidence that cigarette smoke particles induced acti-
vation of the p38 MAPK inflammatory signalling and
phosphorylation of its downstream ATF-2 [57].
In this work, we observed that 30 nm SiO2NP were
more rapidly taken up by both THP-1 and A549 cells
than the nominally 400 nm SiO2N P( m a d eb yt h es a m e
synthesis route and with similar surface characteristics).
Rapid internalisation was seen after 1 hr incubation at
Figure 8 Effect of labelled 30 nm SiO2NP on ATF- translocation at 37°C, under low temperature condition and in the presence of
metabolic inhibitor. THP-1 (A), or A549 (B) cells were growing on 96-well plates and exposed to labelled 30 nm SiO2NP (L-SiO2NP) for over 24
h pried at 37°C, 4°C and 0.1% sodium azide. Cells were labelled with the Cellomics
® HCS reagent kit for ATF-2 activation. High content screening
analysis for nuclear translocation of ATF-2 was performed using an automated IN Cell Analyzer 1000 microscope equipped with IN Cell
Investigator image analysis software that quantifies nuclear to cytoplasmic fluorescence intensity. Statistical analysis was carried out by 2-way
ANOVA with Bonferroni post-test analysis and statistically significant data is reported by “*” symbol, for p < 0.05; “**” p < 0.01; “***” for p < 0.001.
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dent endocytotic process possibly associated with two
competing mechanisms such as diffusion (after 1 h) and
sedimentation (after 3 h). This has been previously
reported by Limbach and co-workers [58] as a particle
transport mechanism issue which has been associated
with the nature of the cell under investigation and the
quantitative treatment of the nanomaterial under inves-
tigation. A recent work from Shapero and co-workers
[59], described and explained the detailed uptake and
localization time course of SiO2NP of different sizes (50,
100 and 300 nm) by one of the cell line used, in this
work A549 cells.
In agreement with previous studies [60], we have also
demonstrated that the SiO2NP uptake was eliminated at
lower temperature (4°C) in THP-1 and A549 cells [60].
Sodium azide is widely used both in vivo and in vitro as
an inhibitor of cellular respiration. It acts by inhibiting
cytochrome C oxidase, the last enzyme in the mitochon-
drial electron transport chain, and thereby produces a
drop in intracellular ATP concentration [61]. The
uptake of SiO2NP into A549 pre-treated with commonly
used concentration of sodium azide (0.1%) was comple-
tely blocked thus suggesting that the uptake mechanism
occurs through an energy dependent process. In con-
trast, this concentration of sodium azide could not effi-
ciently inhibit SiO2NP uptake in THP-1 cells. Other
studies have also reported on alternative uptake
mechanisms such as clathrin-mediated endocytosis,
caveolae/lipid raft-mediated endocytosis, macropinocyto-
sis, or phagocytosis [62,63].
In light of this evidence, a broader understanding on
the mechanism of interaction between the nanoparticles
and cell lines used was also explored since each of the
cell lines exhibited different responses to the various
SiO2NP. Overall the HCS measured cytotoxicity was
higher in THP-1 compared to A549 cells. In addition,
THP-1 cells showed reduction in the cell viability, as
shown in Figure 4. This reduction is dependent on the
particle concentration, particle size, and exposure time.
It has been previously reported by other researchers that
the reduction of cell viability is concentration-dependent
Figure 9 Effect of SiO2NP on the phosphorylation of JNK1/2 and p38 in human lung epithelial cells. A549 cells were treated with 80 nm
SiO2NP for multiple time points ranging from 15 min to 24 h or left untreated (N/T) and lysed. Cell lysates (20 μg each) were resolved by SDS-
PAGE and after Western blotting probed with anti-phospho-JNK1/2 or JNK1/2 (A), or anti-phospho-p38 or p38 (B). Relative densitometric analysis
of the individual bands was performed and presented. Data are mean ± S.E.M. of three independent experiments. 2-way ANOVA with Bonferroni
post-test analysis was carried out on the experimental data, with respect to corresponding controls, and statistically significant data is reported
by “*” symbol, for p < 0.05; “**” p < 0.01; “***” for p < 0.001.
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SiO2NP has previously been addressed in different cell
systems such as A549, Mono Mac 6 and THP-1 and
EAHY926 cell lines [66,67]. It has been shown in vivo
that amorphous SiO2NP are less toxic than their crystal-
line form [68,69].
We have also demonstrated a particle size-dependence
of the cytotoxic response in THP-1 cells. As seen in Fig-
ures 4, the smaller sizes (20, and 30 nm) of the tested
sodium ion stabilized, and non- stabilized SiO2NP at 0.5
mg/ml caused an inhibition in cell viability after 24 h
incubation period. Whereas, all tested doses of the 80
and 400 nm-size SiO2NP caused a significant decrease
in the viability of THP-1 cells. We observed that the
peak of internalised 400 nm SiO2NP remained constant
in the cytosol of THP-1 cells after 24 h exposure, while
the cellular uptake level of 30 nm SiO2NP decreased
after 24 h exposure. From this, we hypothesise that the
large sized particles (400 nm SiO2NP) either remained
within the cells or a delay in the exocytosis process
induced significant decrease of the cell viability. This
emphasises the need to further address the bi-directional
issues (endo- and exo- cytotic process) involving the
nanoparticle transport routes and mechanisms in
human cells.
A549 cells are a well characterised in vitro model and
have been extensively used for assessing cytotoxicity,
including nanomaterials-induced cytotoxicity [70,71]. The
findings of these works show that there was no significant
r e d u c t i o ni nc e l lv i a b i l i t yc a u s e db ya n yo ft h et e s t e d
SiO2NP at any of the doses applied (0.01, 0.1, and 0.5 mg/
ml). Conversely to previous work by Lin et al. [30] which
showed a significant reduction in the viability of A549
cells caused by 15 nm and 46 nm amorphous SiO2NP that
exhibited similar cytotoxicity. Their conclusion was that
the 15 nm and 46 nm SiO2NP aggregated to form hydro-
dynamic clusters of ranging sizes between 590 nm to 617
nm, respectively with subsequent toxicity due to their
aggregation [30]. Conversely, we did not find a significant
reduction in cell number even at the highest concentration
tested (0.5 mg/ml) either by 20 nm nor 400 nm SiO2NP.
In our study, the size and size-distribution of the SiO2NP
used here were extensively examined and characterised
across the Nanointeract consortium (Framework Pro-
gramme 6 funded project), as reported by Barnes et al.
[46]; this is an important consideration when using the
nanoparticles for biomedical applications. In addition, our
TEM and Light Scattering measurement was also carried
out on retrieved 40 nm particles, and this did not show
any significant aggregation.
To determine if surface coating of the SiO2NP affects
the cellular interaction, we also evaluated the effect of
alumina coating on SiO2NP cytotoxicity. We found that
the alumina coating of positively charged SiO2NP did not
significantly inhibit cell growth, at any dose, in any of the
two cell types studied. In vitro studies also suggested that
alumina coating pre-treatment reduced the cytotoxicity
of silica [72] and mitochondrial depolarisation [73]. The
mechanism by which alumina coating reduces silica toxi-
city is still unclear, nonetheless our latest findings are in
opposition with the general perception that cationic spe-
cies are more toxic to cells than anionic ones [74], and
this was consistent for both the cytotoxicity and activa-
tion of ATF-2 translocation. Furthermore, it has been
suggested that alumina reduces the ability of silica to
generate hydroxyl radicals in the presence of hydrogen
peroxide [72] and their effects are believed to alter the
interaction of SiO2NP with cell membranes [75]. This
was demonstrated in our study by the investigation of the
40 nm alumina coated SiO2NP which suppressed the
lysosomal alterations in both THP-1 and A549 cells.
Following the uptake of SiO2NP, these may interact
with phagolysosomal membranes leading to the release
of lysosomal enzymes into the cytosol and subsequently
causing cell death in phagocytic cells [76], or epithelial
cells [77]. This was qualitatively and quantitatively
assessed in this work. For instance, despite the reduction
of cell viability of THP-1 cells at concentrations below
0.5 mg/ml, the lysosomal mass/pH changes were only
noted at the highest 0.5 mg/ml of 20, 30 and 80 nm
SiO2N P .T h i si si na g r e e m e n tw i t hp r e v i o u sw o r kb y
s o m eo ft h ea u t h o r sw h e r et h e yd e m o n s t r a t e ds u c h
alteration of lysosomal mass/pH in THP-1 to be linked
to nanoparticles and also the cell line used [7].
Figure 10 Effect of p38 or JNK1/2 inhibition on 80 nm- size of
SiO2NP induced ATF-2 activation. A549 cells growing on 96-well
plates were pre-treated with 10 μM specific inhibitors of p38
(SB202190), or JNK (SP600125) for 1 h and exposed to SiO2NP or
anisomycin (positive control) for 24 h. Cells were labelled with the
Cellomics
® HCS reagent kit for ATF-2 activation. High content
screening analysis for nuclear translocation of ATF-2 was performed
using an automated IN Cell Analyzer 1000 microscope equipped
with IN Cell Investigator image analysis software that quantifies
nuclear to cytoplasmic fluorescence intensity. Statistical analysis was
carried out by Mann-whitney U test then used to assess the
statistical significance differences. p-values of p < 0.05; “**” p < 0.01;
“***” for p < 0.001 were considered to be statistically significant.
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somal mass/pH was increased following treatment with
nominally 20, 80 or 400 nm particles and the latter
SiO2NP used caused some cell biological changes (e.g.
cell stress, membrane permeability, and lysosomal mass/
pH), despite cell proliferation was not inhibited as shown
by the cell viability measurements. In fact, it has been
suggested that loss in lysosomal integrity can be attribu-
ted to apoptotic responses [78], sphingosine [79], TNF-a
[80], Fas [81], lysosomal photodamage [82] or lysosomal
permeability [73]. Importantly, in this study we found
that alumina coated 40 nm SiO2NP showed lower cyto-
toxicity in all measured parameters and lower ATF-2
activation stress response. This might be linked to a pos-
sible reduction by the SiO2NP to produce hydroxyl radi-
cals in situ in cells. From the results presented in this
study, we propose that SiO2NP enter the cells by endocy-
tosis and activate the SAPK pathway. Activated JNK and
p38 further trigger the nuclear translocation of transcrip-
tion factor ATF-2 with a consequent induction of stress
response signalling pathways (Figure 11).
Finally, our results are in agreement with other cyto-
toxicity studies [31,32,83] demonstrating low cytotoxi-
city response induced by SiO2NP (below <500 nm).
However, in this paper we present further evidence of
gene stress response induced by these materials, which
has not been previously measured by other techniques
[46,61]. This opens interesting exploratory pathway
where there is a pressing need for further in-depth
gene-associated studies towards the elucidation of the
SiO2NP-cells interaction mechanisms aimed at establish-
ing the safe application of this promising nanomaterials.
Conclusions
This study showed that at concentrations below 0.5 mg/
ml of the amorphous SiO2NP tested (20, 30, 40, 80 and
400 nm), a low degree of cytotoxicity was observed
across the two cell lines adopted (THP-1 and A549
cells). Interestingly, the cell lines did not show any sig-
nificant toxic response to the alumina coated SiO2NP (e.
g., 40 nm SiO2NP). In this paper, we demonstrated for
the first time that SiO2N Pa r ea b l et oi n d u c ep 3 8a n d
JNK MAPK activation and phosphorylation of their
downstream ATF-2 target, which also clearly reflect the
nature of particular cell type. In addition, we also regis-
tered a close relation between silica-induced cytotoxicity
and changes to the structure or activity of detected cel-
lular compartments (e.g., lysosomal and cell membrane)
by the use of HCS which detected significant dose and
particle size-dependent changes in parameters related to
these compartments.
Based on our results, it may be speculated that con-
tinuous exposure to nanoparticles, even of relatively
biologically “inert” nature, could impose a risk to
human health. However, it may be possible to reduce
such unwanted effects by surface modification of nano-
materials, for example via alumina coating of SiO2NP,
thereby reducing the surface reactivity of the NPs. A
much better mechanistic understanding of nanoparti-
cles and their properties will support the development
and evaluation of potentially reduced risk nano-pro-
ducts for biomedical applications, and HCS offers an
ideal platform for the type of screening data needed
for this purpose.
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